Gambia

PATH is on the front lines of an effort to defeat meningitis by 2030.

This fact sheet provides an overview of the MVP Access Program, an initiative that grants researchers access to data sets and frozen serum samples collected during the MenAfriVac ® clinical studies in Africa. The fact sheet outlines MenAfriVac's ® development history, qualified uses of data, and how to request data and/or serum access.

Perspectives from a mom, an immunization manager, and clinical investigators.

Two clinicians reflect on evaluating early vaccines in The Gambia

Perspectives from The Gambia’s immunization program manager

One mother’s story about enrolling her child in a vaccine trial.

PATH and its partners have been conducting clinical trials to evaluate a pneumococcal vaccine designed to meet needs in low-resource countries.

Mark Alderson won’t rest easy until he solves one of the biggest problems in global health: a vaccine against pneumonia.